BIOA
BIOA
NASDAQ · Pharmaceuticals

Bioage Labs Inc

$8.20
-0.26 (-3.07%)
As of Sep 23, 2:05 PM ET ·
Analyst Consensus
Strong Buy
15
Analysts
High
Coverage
Buy 12 80%
Hold 3 20%
Sell 0 0%
Price Target
Analyst Price Target +60.2% upside
Low Target $9.99
Average Target $13.14
High Target $19.07
Current Price $8.20
Current
$8.20
Target
$13.14
$9.99 $13.14 avg $19.07
Scenario Analysis
Bear Case
$9.99
21.8%
Low target
Base Case
$13.14
+60.2%
Avg target
Bull Case
$19.07
+132.6%
High target
Risk/Reward
6.1x
Highly favorable
Price in Context
52-Week High
$25.96
-68.4% from high
52-Week Low
$4.84
+69.4% from low
Target vs 52W High
$13.14
-49.4% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
Strong Buy 38 79% $1,330.33 +15.8%
RDY
Dr. Reddy's Laboratories
Strong Sell 45 31% +0.0%
JNJ
Johnson & Johnson
Buy 31 71% $299.55 +11.9%
MRK
Merck & Co. Inc.
Buy 36 72% $159.27 +7.9%
PFE
Pfizer Inc.
Hold 36 39% $33.90 +20.9%
BMY
Bristol-Myers Squibb Co
Hold 35 43% $174.50 +180.3%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 16 88% $36.26 -38.0%
ZTS
Zoetis Inc
Hold 24 50% $209.87 +192.4%